EW
Edwards Lifesciences Corp
86.30$
+0.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -66.8% | -139.2% | – | -5.3% | -20.3% | +0.0% | +3.5% | +97.7% | -21.4% | -90.3% | +1,388.4% | – | |
| – | -0.5% | +4.9% | +2.9% | -12.9% | +6.1% | +0.0% | +4.1% | +2.9% | +8.9% | -4.2% | +4.4% | – | |
| – | -6.4% | +46.2% | -1.6% | -4.1% | -4.5% | +0.0% | -6.7% | +9.9% | -4.9% | +15.8% | -7.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -122.0% | – | – | – | +204.6% | -297.2% | – | – | |
| – | +83.7% | -16.0% | +0.1% | -62.6% | +75.5% | +0.0% | -12.0% | +16.6% | +69.4% | -33.4% | +3.1% | – | |
| – | -84.2% | +347.5% | +97.8% | +2,064.8% | -96.8% | +0.0% | -301.8% | +148.6% | -53.6% | -53.2% | +108.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +157.1% | -100.0% | +78,950.0% | +469.9% | -71.3% | -19.3% | -97.4% | – | -125.9% | +1,185.2% | -89.8% | – | |
| – | +188.3% | – | -256.6% | +911.1% | -73.6% | +0.0% | – | -1,504.4% | -98.5% | +3,857.9% | -99.9% | – | |
| – | -172.6% | – | +429.8% | +374.3% | -95.6% | +0.0% | +56.9% | -521.5% | – | -301.1% | – | – | |
| – | -90.2% | -496.6% | – | +11.8% | -29.9% | +0.0% | +7.4% | +114.3% | -31.5% | -106.0% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.